| Literature DB >> 8274189 |
F Garrido1, T Cabrera, A Concha, S Glew, F Ruiz-Cabello, P L Stern.
Abstract
HLA expression is frequently altered in tumours compared to the tissue from which they originate. Given the central role of MHC products in the restriction of T-cell recognition, regulation of tumour HLA expression might be a strategy for the evasion of immune surveillance by the malignant cells. Federico Garrido, Peter Stern and colleagues present data from a variety of tumour types, suggesting that HLA class I alterations may occur at a particular step between the development of an in situ lesion and an invasive carcinoma.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8274189 DOI: 10.1016/0167-5699(93)90264-L
Source DB: PubMed Journal: Immunol Today ISSN: 0167-5699